When times got tough, the bio­phar­ma in­dus­try hit the Zoom but­ton and kept things mov­ing at a multi­bil­lion-dol­lar clip

Don’t ever un­der­es­ti­mate bio­phar­ma’s abil­i­ty to grab ahold of an op­por­tu­ni­ty, even if they can’t close a deal with a hand­shake.

While re­tail and oth­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.